Browsing by Author Layos, Laura
Showing results 1 to 6 of 6
| Issue Date | Title | Author(s) |
|---|---|---|
| 6-Mar-2017 | Adherence to capecitabine in preoperative treatment of stage II and III rectal cancer: do we need to worry? | Font, R.; Espinàs Piñol, Josep Alfons; Layos, Laura; Martínez Villacampa, Mercedes; Capdevila, Jaume; Tobeña, M.; Pisa, Aleydis; Pericay, Carles; Lezcano, C.; Fort, E.; Cardona, Ignasi; Berga, N.; Solà, Judit; Borràs Andrés, Josep Maria |
| 19-Apr-2016 | Curcumin mediates oxaliplatin-acquired resistance reversion in colorectal cancer cell lines through modulation of CXC-Chemokine/NF-κB signalling pathway | Ruiz de Porras, Vicenç; Bystrup, Sara; Martínez Cardús, Anna; Pluvinet Ortega, Raquel; Sumoy, Lauro; Howells, Lynne; James, Mark I.; Iwuji, Chinenye; Manzano, José Luis; Layos, Laura; Buges, Cristina; Abad, Albert; Martínez Balibrea, Eva |
| 27-Jan-2022 | Modulation of DNA damage response by SAM and HD Domain containing Deoxynucleoside Triphosphate Triphosphohydrolase (SAMHD1) determines prognosis and treatment efficacy in different solid tumor types | Felip, Eudald; Gutiérrez-Chamorro, Lucía; Gómez, Maica; Garcia-Vidal, Edurne; Romeo, Margarita; Morán, Teresa; Layos, Laura; Pérez-Roca, Laia; Riveira-Muñoz, Eva; Clotet, Bonaventura, 1953-; Fernández, Pedro Luis; Mesía Nin, Ricard; Martínez Cardús, Anna; Ballana, Ester; Margelí, Mireia |
| 1-Jun-2016 | Resistant mechanisms to BRAF inhibitors in melanoma | Manzano, José Luis; Layos, Laura; Bugés, Cristina; Llanos Gil, María de los; Vila, Laia; Martínez Balibrea, Eva; Martínez Cardús, Anna |
| 11-Oct-2019 | Tumor Expression of Cyclin-Dependent Kinase 5 (Cdk5) Is a Prognostic Biomarker and Predicts Outcome of Oxaliplatin-Treated Metastatic Colorectal Cancer Patients | Ruiz de Porras, Vicenç; Bystrup, Sara; Cabrero de las Heras, Sara; Musulén, Eva; Palomero, Luis; Alonso Aguado, Maria Henar; Nieto, Rocio; Arango, Diego; Moreno Aguado, Víctor; Queralt, Cristina; Manzano, José Luis; Layos, Laura; Bugés, Cristina; Martínez Balibrea, Eva |
| 13-Jul-2010 | UGT1A and TYMS genetic variants predict toxicity and response of colorectal cancer patients treated with first-line irinotecan and fluorouracil combination therapy | Martínez Balibrea, Eva; Abad, Albert; Martínez Cardús, Anna; Ginés, A.; Valladares, M.; Navarro, M.; Aranda, Enrique; Marcuello, Eugenio; Benavides, M.; Massutí, B.; Carrato, A.; Layos, Laura; Manzano, José Luis; Moreno Aguado, Víctor |